Clinical Reflections®: Achieving Success in RA Assessment and Management: A Learner Pathway to Improve Patient Outcomes

Activity Overview

This unique educational initiative harnesses the power of reflection and recognition of suboptimal approaches to patient management to allow you to rethink clinical decisions based on the scenarios presented and to modify management plans accordingly. You can compare your responses to interactive questions with those of your peers and learn from our expert faculty.

CE Credit Expired

Target Audience

Rheumatologists – Relevant Terms: Rheumatoid Arthritis

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Discriminate between the effects of the tumor necrosis factor alpha (TNFα) and interleukin 6 (IL-6) signaling pathways in the pathophysiology of rheumatoid arthritis (RA) and provide a rationale for anti-cytokine therapy as a treatment approach
  • Incorporate validated and guideline-recommended disease activity monitoring to guide appropriate management for patients with rheumatoid arthritis
  • Develop individualized treatment plans for patients with rheumatoid arthritis that integrate new and emerging targeted and non-TNF disease modifying antirheumatic drugs (bMARDs) based on safety and efficacy data
  • Distinguish between TNF cycling and switching and prepare treatment plans that improve patient outcomes based on an understanding of the differences between the 2 options
  • Integrate shared decision making and other patient education strategies for patients with rheumatoid arthritis

Activity Faculty

Jeffrey R. Curtis, MD, MS, MPH

Jeffrey R. Curtis, MD, MS, MPH (Chair)

William J. Koopman Endowed Professor, Rheumatology and Immunology
Professor, Medicine, Division of Clinical Immunology and Rheumatology
Director, University of Alabama at Birmingham (UAB) Arthritis Clinical Intervention Program
Co-Director, UAB Center for Education and Research on Therapeutics (CERTS) of Musculoskeletal Disorders
Co-Director, UAB Pharmacoepidemiology and Pharmacoeconomics (PEER) Unit
University of Alabama at Birmingham
Birmingham, AL

Martin Jan Bergman, MD, FACR, FACP, FCPP

Martin Jan Bergman, MD, FACR, FACP, FCPP

Clinical Associate Professor, Medicine
Drexel University School of Medicine
Philadelphia, PA
Chief, Division of Rheumatology
Taylor Hospital
Ridley Park, PA

Peter C. Taylor, MA, BM, BCh, PhD, FRCP, FRCPE

Peter C. Taylor, MA, BM, BCh, PhD, FRCP, FRCPE

Norman Collison Professor, Musculoskeletal Sciences
Fellow, St. Peter’s College
Head, Clinical Sciences, Biomedical Research Unit Inflammation Theme
Botnar Research Centre
University of Oxford
Oxford, England (UK)